Bibliography — Mathias Uhlén
April 2011
362. |
Wållberg H, Löfdahl PK, Tschapalda K, Uhlén M, Tolmachev V, Nygren PK, Ståhl S. Affinity recovery of eight HER2-binding affibody variants using an anti-idiotypic affibody molecule as capture ligand. Protein Expr Purif. 2011 Mar;76(1):127-35. |
361. |
Mälarstig A, Silveira A, Wågsäter D, Ohrvik J, Bäcklund A, Samnegård A, Khademi M, Hellenius ML, Leander K, Olsson T, Uhlén M, de Faire U, Eriksson P, Hamsten A. Plasma CD93 Concentration is a Potential Novel Biomarker for Coronary Artery Disease. J Intern Med. 2011 Feb 19. doi: 10.1111/j.1365-2796.2011.02364.x. |
360. |
Joensson HN, Uhlén M, Svahn HA. Droplet size based separation by deterministic lateral displacement-separating droplets by cell-induced shrinking. Lab Chip. 2011 Feb 14. [Epub ahead of print] |
359. |
Klütsch CF, Seppälä EH, Fall T, Uhlén M, Hedhammar A, Lohi H, Savolainen P. Regional occurrence, high frequency but low diversity of mitochondrial DNA haplogroup d1 suggests a recent dog-wolf hybridization in Scandinavia. Anim Genet. 2011 Feb;42(1):100-3. |
358. |
Uhlen M, Svahn HA. Affinity reagents for lab on chips. Lab Chip. 2011 Feb 1. [Epub ahead of print] |
357. |
Brennan DJ, Laursen H, O'Connor DP, Borgquist S, Uhlen M, Gallagher WM, Pontén F, Millikan RC, Rydén L, Jirström K. Tumor-specific HMG-CoA reductase expression in primary premenopausal breast cancer predicts response to tamoxifen. Breast Cancer Res. 2011 Jan 31;13(1):R12. |
356. |
Gustavsson E, Ek S, Steen J, Kristensson M, Algenäs C, Uhlén M, Wingren C, Ottosson J, Hober S, Borrebaeck CA. Surrogate antigens as targets for proteome-wide binder selection. N Biotechnol. 2011 Jan 11. [Epub ahead of print] |
355. |
Falk R, Ramström M, Eriksson C, Uhlén M, Wernérus H, Hober S. Targeted protein pullout from human tissue samples using competitive elution. Biotechnol J. 2011 Jan;6(1):28-37. PubMed PMID: 21170982. |
354. |
Xu X, Patrakka J, Sistani L, Uhlen M, Jalanko H, Betsholtz C, Tryggvason K. Expression of novel podocyte-associated proteins sult1b1 and ankrd25. Nephron Exp Nephrol. 2011;117(2):e39-46. |
353. |
Rockberg J, Löfblom
J, Hjelm B, Ståhl S, Uhlen M. (2010) Epitope mapping
using gram-positive surface display. Curr Protoc Immunol.
9:Unit 9.9. |
352. |
Ehlen A, Brennan DJ, Nodin
B, O'Connor DP, Eberhard J, Alvarado-Kristensson M, Jeffrey IB,
Manjer J, Brandstedt J, Uhlen M, Ponten F, Jirstrom K.
(2010) Expression of the RNA-binding protein RBM3 is associated
with a favourable prognosis and cisplatin sensitivity in epithelial
ovarian cancer. J Transl Med. 8(1):78. |
351. |
Xu X, Patrakka J, Sistani
L, Uhlen M, Jalanko H, Betsholtz C, Tryggvason K. (2010)
Expression of Novel Podocyte-Associated Proteins sult1b1 and ankrd25.
Nephron Exp Nephrol. 117(2):e39-e46. |
| 350. |
Schwenk JM, Igel U, Neiman
M, Langen H, Becker C, Bjartell A, Ponten F, Wiklund F, Grönberg
H, Nilsson P, Uhlen M. (2010) Towards next generation plasma
profiling via heat-induced epitope retrieval and array-based assays.
Mol Cell Proteomics., in press [Epub ahead of print] |
| 349. |
Lundberg E, Uhlen M.
(2010) Creation of an antibody-based subcellular protein atlas.
Proteomics, in press [Epub ahead of print] |
348. |
Gardberg M, Talvinen K, Kaipio
K, Iljin K, Kampf C, Uhlen M, Carpen O. Characterization
of Diaphanous-related formin FMNL2 in human tissues. BMC Cell
Biol. 2010 Jul 15;11:55. |
347. |
Bourbeillon J, et al
(2010) Minimum information about a protein affinity reagent (MIAPAR).
Nature Biotechnol. 28(7):650-3. |
346. |
Furusato B, Mohamed A, Uhlen
M, Rhim JS. (2010) CXCR4 and cancer. Pathol Int.
60(7):497-505. |
345. |
Lindskog C, Asplund A, Engkvist
M, Uhlen M, Korsgren O, Ponten F. (2010) Antibody-based
proteomics for discovery and exploration of proteins expressed
in pancreatic islets. Discov Med. 9(49):565-78. |
344. |
Naukkarinen J, et al.
(2010) Use of genome-wide expression data to mine the "Gray
Zone" of GWA studies leads to novel candidate obesity genes.
PLoS Genet. 6(6):e1000976. |
343. |
Mulder J, Spence L, Tortoriello
G, Dinieri JA, Uhlen M, Shui B, Kotlikoff MI, Yanagawa Y, Aujard
F, Hökfelt T, Hurd YL, Harkany T. (2010) Secretagogin
is a Ca2+-binding protein identifying prospective extended amygdala
neurons in the developing mammalian telencephalon. Eur J Neurosci.
31(12):2166-77. |
342. |
Jonasson K, Berglund L, Uhlen
M. (2010) The 6th HUPO Antibody Initiative (HAI) workshop: sharing
data about affinity reagents and other recent developments. September
2009, Toronto, Canada. Proteomics. 10(11):2066-8. |
341. |
Klütsch CF, Seppvaa
EH, Fall T, Uhlen M, Hedhammar A, Lohi H, Savolainen P.
(2010) Regional occurrence, high frequency but low diversity of
mitochondrial DNA haplogroup d1 suggests a recent dog-wolf hybridization
in Scandinavia. Anim Genet.., in press [Epub ahead of
print] |
340. |
Thorgeirsson TE, et al
(2010) Sequence variants at CHRNB3-CHRNA6 and
CYP2A6 affect smoking behavior. Nature Genet.;42(5):448-53. |
339. |
International Cancer Genome
Consortium (2010) International network of cancer genome
projects. Nature. 464(7291):993-8. |
338. |
Brennan DJ, Bröndstedt
J, Rexhepaj E, Foley M, Ponten F, Uhlen M, Gallagher WM, O'Connor
DP, O'Herlihy C, Jirstrom K. (2010) Tumour-specific HMG-CoAR
is an independent predictor of recurrence free survival in epithelial
ovarian cancer. BMC Cancer 1;10:125. |
337. |
Holgersson G, Ekman S, Reizenstein
J, Bergqvist M, Ponten F, Uhlen M, Magnusson K, Jonnalagadda P,
Asplund A, Strömberg S, Linder A, Blomquist E,
Liljeholm M, Löden B, Hellström K, Bergström S.
(2010) Molecular profiling using tissue microarrays as a tool
to identify predictive biomarkers in laryngeal cancer
treated with radiotherapy. Cancer Genomics Proteomics.
7(1):1-7. |
336. |
Fagerberg L, Jonasson K,
von Heijne G, Uhlen M, Berglund L. (2010) Prediction of
the human membrane proteome. Proteomics 10(6):1141-9. |
335. |
Gloriam DE et al (2010)
A community standard format for the representation of protein
affinity reagents. Mol Cell Proteomics.9(1):1-10. |
|
